Bronchial Asthma
Conditions
Keywords
bronchial asthma, cold type, heat type, Asthenia type, TCM syndrome, symptoms, physical signs
Brief summary
Bronchial asthma is a common disease and frequently encountered disease of respiratory apparatus. It has very complex mechanism and multiple inducing factors. This study will focus on a new Chinese therapy on Bronchial asthma, analyzing the treatment mechanism of internal and external use, based on Traditional Chinese Medicine (TCM) theory and clinical practice. The study will also investigate the efficacy of the Chinese drugs and treatments on Bronchial asthma, and provide an effective therapy for this disease.
Interventions
OTHERwarming lung and relieving asthmatic granule and Securing origin and warming lung emplastrum
warming lung and relieving asthmatic granule:once 1 bag, 3 times a day. Securing origin and warming lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day
OTHERclearing lung and relieving asthmatic granule and securing origin and clearing lung emplastrum
clearing lung and relieving asthmatic granule: once 1 bag, 3 times a day. securing origin and clearing lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day
OTHERsecuring origin and relieving asthmatic granule and securing origin and nourishing lung emplastrum
securing origin and relieving asthmatic granule: once 1 bag, 3 times a day. securing origin and nourishing lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day
DRUGTheophylline Sustained-release Tablets and budesonide suspension
Theophylline Sustained-release Tablets 0.2g a time, twice a day. budesonide suspension for inhalation 100ug, twice a day
Sponsors
Shenyang Huanggu District Central Hospital
Benxi City hospital of Chinese medicine
Anshan Central Hospital
Liaoning University of Traditional Chinese Medicine
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Age between 18 to 65 years old; * Patients with mild-to-moderate bronchial asthma on attacking stage; * Without cardiopulmonary or other complications; * To comply with the diagnostic standard of bronchial asthma in western medicine and TCM syndrome differentiation; * Informed consent form is required to be signed.
Exclusion criteria
* Older than 65 years or younger than 18 years old; * Pregnant woman or suckling period woman; * Patients combine serious primary disease in liver, renal, cardiovascular and cerebrovascular, hemopoietic system diseases,or psychosis. * Severe levels of disease is between severe and critical extent. Combine Pulmonary Heart Disease or respiratory failure; * Irritable the physique, or allergic to the given composition of drugs in this research; * Patients who are in the process of other clinical research.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| primary Symptom | 30 days | Symptom: wheezing, cough, choking |
| physical sign | 30 days | physical sign: wheezing sound |
| assistant examination | 30 days | Pulmonary function: mend matters of FEV1, PEF, FEV1/FVC |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| physical sign | 30 days | physical sign: tongue appearance and Pulse condition |
| Secondary Symptom | 30 days | Symptom: expectoration, fever, Aversion to wind and cold |
Outcome results
None listed